Antidiabetics MOA Flashcards
Insulin (MOA)
Activate insulin receptors
Sulfonylureas (MOA)
Insulin secretagogues: close k channels in b cells
increase insulin release
Glitinides (MOA)
Insulin secretagogues: similar to sulfonylureas with some overlap in binding sites
Biguanides (MOA)
Obscure: reduced hepatic and renal gluconeogenesis
Alpha-Glucosidase Inhibtors (MOA)
Inhibit intestinal a-glucosidase
Thiazolidinediones (Pioglitazone) (MOA)
Regulates gene expression by binding to PPAR-y and PPAR-a
Thiazolidinediones (Rosiglitazone) (MOA)
Regulates gene expression by binding to PPAR-y
Glucagon-like Polypeptide-1 receptor agonists (MOA)
Analog of GLP-1: Binds to GLP-1 Receptors
Dipeptidyl Peptidase-4 inhibitors (MOA)
DPP-4 inhibitor: Block degradation of GLP-1
Raises circulating GLP-1 levels
Amylin Analog (MOA)
Analog of amylin: binds to amylin receptors
Bile acid sequestrant (MOA)
Bile acid binder
SGLT2 Inhibitors (MOA)
Inhibit renal glucose absorption via SGLT2
Activate insulin receptors
Insulin
Insulin secretagogues: close k channels in b cells
increase insulin release
Sulfonylureas
Insulin secretagogues: similar to sulfonylureas with some overlap in binding sites
Glitinides
Obscure: reduced hepatic and renal gluconeogenesis
Biguanides
Inhibit intestinal a-glucosidase
Alpha-Glucosidase inhibitors
Regulates gene expression by binding to PPAR-y and PPAR-a
Thiazolidinediones (Pioglitazone)
Regulates gene expression by binding to PPAR-y
Thiazolidinediones (Rosiglitazone)
Analog of GLP-1: Binds to GLP-1 Receptors
Glucagon-like Polypeptide-1 receptor agonists
DPP-4 inhibitor: Block degradation of GLP-1
Raises circulating GLP-1 levels
Dipeptidyl Peptidase-4 inhibitors
Analog of amylin: binds to amylin receptors
Amylin Analog
Bile acid binder
Bile acid sequestrant
Inhibit renal glucose absorption via SGLT2
SGLT2 inhibitors